ArticleJournal of nephrology2023

Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.

Gabriel Ștefan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.